Dr. Shakeel Hoosdally is a medicinal chemist with over 25 years of experience in academic leadership and scientific research. He serves as Head of the Chemistry Department at the Ministry of Education and Higher Tertiary Scientific Research in Mauritius.

Dr. Hoosdally holds a Ph.D. in Pharmacology and Toxicology, an M.Sc. in Drug Design and Drug Discovery, and a Postgraduate Diploma in Medicinal Chemistry. His research focuses on computational oncology, molecular docking, and the discovery of cryptic druggable pockets, particularly targeting TP53 mutations in cancer. He has published peer-reviewed articles and book chapters in the fields of cancer therapeutics, precision pharmacology, and drug repurposing. He brings expertise in computer-aided drug design, molecular dynamics, and systems pharmacology, contributing to the development of innovative therapeutic strategies in oncology.

Hany Azzam is a seasoned clinical pharmacist and academician with extensive experience in both hospital and university settings. Currently serving as a Senior Clinical Pharmacist at Dr. Bakhsh Hospital in Jeddah, Saudi Arabia, he specializes in optimizing drug therapy, monitoring patient outcomes, and implementing clinical pharmacy practices. He previously held academic positions at Heliopolis University in Cairo, including Lecturer and Assistant Lecturer of Clinical Pharmacy. Azzam earned his PhD in Pharmacology and Toxicology from Ain Shams University, focusing on tamoxifen resistance in breast cancer. He holds multiple advanced degrees, including Master's degrees in Clinical Pharmacy and Clinical Pharmacology, and is certified by the American Board of Pharmacotherapy (BCPS). His research contributions are published in several peer-reviewed journals, notably in the fields of oncology and pharmacotherapy.

Hao Chen is an accomplished surgical oncologist and academic leader, currently serving as the Director of the Cancer Center and the Science and Technology Department at the Second Hospital of Lanzhou University. He also holds multiple prestigious roles including Director of the Oncology Teaching and Research Office, Drug Clinical Trial Facility (GCP) Office, and the Gastrointestinal Cancer Center of Gansu Province. Chen earned his MBBS from Lanzhou Medical College in 2000, followed by a Master’s in General Surgery from Lanzhou University in 2003. He completed his PhD at Zhejiang University in 2008, with joint training at the University of Florida, where he later held academic positions from 2007 to 2014. His clinical expertise spans minimally invasive and robotic surgery for digestive system cancers such as gastric, liver, colorectal, and pancreatic tumors. With over 230 publications, 36 utility model patents, and supervision of nearly 70 graduate students, his academic impact is extensive. He has led or participated in over 50 significant research projects and clinical trials with funding exceeding 12 million yuan.

Dr. Jagdish Chand, PhD, specializes in the discovery and development of novel therapeutic molecules for neurological disorders, cancer, and diabetes, integrating both computational and experimental methodologies. His research focuses on bridging the gaps between biological pathways, cellular processes, and molecular functions, particularly in polygenic and rare diseases. He employs a comprehensive pipeline combining advanced in-silico techniques with organic synthesis and in vitro validation to translate computational insights into effective therapeutic strategies.